Physician warns unregulated peptides reach patients without purity testing
Obesity medicine specialist Catherine Varney, DO, tells AJMC that products sold outside regulated channels are not verified for what they actually contain.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 5 10:08 ETSource: AJMC
The wire
- 01In an AJMC interview, Catherine Varney, DO, says peptides sold through unregulated channels are not subject to purity testing, leaving content and quality unverified.
- 02Clinicians and pharmacists fielding patient questions about gray-market peptide vials face the same gap: no independent confirmation of identity or purity at the point of sale.
- 03The item is a single clinician interview rather than new testing data, so the scale of contamination or mislabeling in the market remains unquantified.
From the source
Read at ajmc.comUnregulated Peptides Lack Purity Testing: Catherine Varney, DO
